Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit Post published:September 9, 2022 Post category:Press Release
MindMed Announces Positive Results from Collaborators’ Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal Post published:September 9, 2022 Post category:Press Release
Small Pharma to Participate in Upcoming September Investor Conferences Post published:September 8, 2022 Post category:Press Release
Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History Post published:September 8, 2022 Post category:Press Release
Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors Post published:September 8, 2022 Post category:Press Release
Psyence Group Announces Amendment and Closing of Previously Announced Private Placement Post published:September 8, 2022 Post category:Press Release
atai Life Sciences to Participate in September Investor Events Post published:September 8, 2022 Post category:Press Release
Mindset Pharma Files National Patents Protecting Family 1 Application in 16 Different Countries Post published:September 7, 2022 Post category:Press Release
Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global Post published:September 7, 2022 Post category:Press Release
BetterLife and Collaborators to Submit Key Joint Research Publication Post published:September 7, 2022 Post category:Press Release